Medicine for treating diseases of cerebral nerves and cerebral vessels, and preparation method of medicine

Abstract

The invention discloses a medicine for treating diseases of cerebral nerves and cerebral vessels, and a preparation method of the medicine. The medicine is prepared from the following main raw materials: radix salviae miltiorrhizae, motherwort herb, fructus crataegi, rhizoma chuanxiong, safflower, radix astragali seu hedysari, fructus lycii, glossy privet fruit, herba saussureae involucratae, Chinese angelica, semen ziziphi spinosae, and the like. The medicine aims at dissolving blood stasis and thrombus, softening blood vessels, reducing blood pressure and blood fat, adjusting blood glucose content, improving myocardial blood supply and improving the immunologic function, also has the effects of improving microcirculation, recovering the myocardial function, adjusting and improving the endocrine function of heart, brain and kidney, adjusting the functions of the cerebral nerves and resisting aging, is stable and lasting in curative effect and enables relapse to be uneasy to occur after healing; furthermore, the medicine is a pure traditional Chinese medicine biological preparation, and is rapid in absorption, quick in response, high in content of effective components, less in dose, good in taste, safe and free from toxic and side effects.

Description

technical field [0001] The invention relates to the technical field of traditional Chinese medicines, in particular to a medicine for treating cranial nerve and cerebrovascular diseases and a preparation method thereof. Background technique [0002] Encephalopathy is a common disease with the strongest impact, the highest incidence rate and the highest death rate. According to investigations, it ranks in the top three in the mortality rate of various diseases in more than 40 countries in the world, and the number of deaths due to hemiplegia accounts for 22.6% of the total annual death toll. The whole world will claim at least the lives of more than 10 million people every year, so the disease is recognized as one of the "four major killers". In the prevention and treatment of cardiovascular and cerebrovascular diseases, although interventional therapy, surgery, statins, anti-platelet agents and thrombolytic agents of modern medicine have been applied clinically, the curativ...

AI Technical Summary

Problems solved by technology

In the prevention and treatment of cardiovascular and cerebrovascular diseases, although interventional therapy, surgery, statins, anti-platelet agents and thrombolytic agents of modern medicine have been applied clinically, the curative effect is not ideal, and it only achieves the temporary effect of dilating blood vessels and improving circulation. It has little effect on the melting of exfoliated plaque or thrombus flowing in blood vessels, and it is difficult to dissolve thrombosis; and frequent use of such western medicines will easily lead to a decrease in the elasticity of the arterial vessel wall and an increase in fragility, resulting in cerebral infarction gradually turning into cerebral infarction. Severe bleeding occurs again, resulting in a larger infarction, which is difficult to cure, and a small number of patients will have adverse reactions after using it. The side effects are relatively large, and the clinical cure rate is not ideal.

Therefore, the current drugs for the treatment of cardiovascular diseases are still insufficient